<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Pathol Transl Med</journal-id><journal-id journal-id-type="iso-abbrev">J Pathol Transl Med</journal-id><journal-id journal-id-type="publisher-id">JPTM</journal-id><journal-title-group><journal-title>Journal of Pathology and Translational Medicine</journal-title></journal-title-group><issn pub-type="ppub">2383-7837</issn><issn pub-type="epub">2383-7845</issn><publisher><publisher-name>The Korean Society of Pathologists and the Korean Society for Cytopathology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26755360</article-id><article-id pub-id-type="pmc">4963967</article-id><article-id pub-id-type="doi">10.4132/jptm.2015.12.01</article-id><article-id pub-id-type="publisher-id">jptm-2015-12-01</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Study</subject></subj-group></article-categories><title-group><article-title>Isolated Mass-Forming IgG4-Related Cholangitis as an Initial Clinical Presentation of Systemic IgG4-Related Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Seokhwi</given-names></name><xref ref-type="aff" rid="af1-jptm-2015-12-01"/></contrib><contrib contrib-type="author"><name><surname>Bae</surname><given-names>Hyunsik</given-names></name><xref ref-type="aff" rid="af1-jptm-2015-12-01"/></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Misun</given-names></name><xref ref-type="aff" rid="af1-jptm-2015-12-01"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Binnari</given-names></name><xref ref-type="aff" rid="af1-jptm-2015-12-01"/></contrib><contrib contrib-type="author"><name><surname>Heo</surname><given-names>Jin Seok</given-names></name><xref ref-type="aff" rid="af2-jptm-2015-12-01"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ho Seong</given-names></name><xref ref-type="aff" rid="af3-jptm-2015-12-01"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Seung Hee</given-names></name><xref ref-type="aff" rid="af4-jptm-2015-12-01"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Kee-Taek</given-names></name><xref ref-type="corresp" rid="c1-jptm-2015-12-01"/><xref ref-type="aff" rid="af1-jptm-2015-12-01"/></contrib><aff id="af1-jptm-2015-12-01">
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, <country>Korea</country></aff><aff id="af2-jptm-2015-12-01"><label>1</label>Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, <country>Korea</country></aff><aff id="af3-jptm-2015-12-01"><label>2</label>Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, <country>Korea</country></aff><aff id="af4-jptm-2015-12-01"><label>3</label>Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, <country>Korea</country></aff></contrib-group><author-notes><corresp id="c1-jptm-2015-12-01">Corresponding Author Kee-Taek Jang, MD Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-2763 Fax: +82-2-3410-0025 E-mail: <email>kt12.jang@samsung.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>11</day><month>1</month><year>2016</year></pub-date><volume>50</volume><issue>4</issue><fpage>300</fpage><lpage>305</lpage><history><date date-type="received"><day>13</day><month>11</month><year>2015</year></date><date date-type="rev-recd"><day>26</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>1</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology</copyright-statement><copyright-year>2016</copyright-year><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>IgG4-related disease (IgG4-RD) may involve multiple organs. Although it usually presents as diffuse organ involvement, localized mass-forming lesions have been occasionally encountered in pancreas. However, the same pattern has been seldom reported in biliary tract. A 61-year-old male showed a hilar bile duct mass with multiple enlarged lymph nodes in imaging studies and he underwent trisectionectomy under impression of cholangiocarcinoma. Gross examination revealed a mass-like lesion around hilar bile duct. Histopathologically, dense lymphoplasmacytic infiltration and storiform fibrosis were identified without evidence of malignancy. Immunohistochemical stain demonstrated rich IgG4-positive plasma cell infiltration. Follow-up imaging studies disclosed multiple enlarged lymph nodes with involvement of pancreas and perisplenic soft tissue. The lesions have been significantly reduced after steroid treatment, which suggests multi-organ involvement of systemic IgG4-RD. Here, we report an unusual localized mass-forming IgG4-related cholangitis as an initial presentation of IgG4-RD, which was biliary manifestation of systemic IgG4-related autoimmune disease.</p></abstract><kwd-group><kwd>IgG4-related disease</kwd><kwd>Bile ducts</kwd><kwd>Mass-forming</kwd><kwd>Cholangiocarcinoma</kwd></kwd-group></article-meta></front><body><p>IgG4-related disease (IgG4-RD) may involve multiple organs including pancreas, head and neck region, kidney, lung, retroperitoneum, and lymph node [<xref rid="b1-jptm-2015-12-01" ref-type="bibr">1</xref>]. Histologically, it is characterized by lymphoplasmacytic infiltration, storiform fibrosis and/or obliterative phlebitis with IgG4 immunohistochemical reactivity in plasma cells [<xref rid="b2-jptm-2015-12-01" ref-type="bibr">2</xref>]. In addition to histologic findings, serum IgG4 level is often elevated in patients with IgG4-RD [<xref rid="b3-jptm-2015-12-01" ref-type="bibr">3</xref>,<xref rid="b4-jptm-2015-12-01" ref-type="bibr">4</xref>]. It is not difficult to diagnose IgG4-RD if an involved organ shows diffuse enlargement with an elevated serum IgG4 level. However, it may not be easy to suspect IgG4-RD if the lesion presents as a localized mass-forming lesion rather than diffuse organ involvement. Although localized mass-forming IgG4-related autoimmune pancreatitis has been reported occasionally [<xref rid="b5-jptm-2015-12-01" ref-type="bibr">5</xref>-<xref rid="b7-jptm-2015-12-01" ref-type="bibr">7</xref>], such manifestation in biliary tract has seldom been described in the literature. In addition, most reported biliary cases had simultaneous segmental involvement of bile duct wall as well as massforming lesions [<xref rid="b8-jptm-2015-12-01" ref-type="bibr">8</xref>-<xref rid="b10-jptm-2015-12-01" ref-type="bibr">10</xref>]. Here, we report a case of localized mass-forming IgG4-related cholangitis, which mimicked hilar cholangiocarcinoma and later progressed to multi-organ involving IgG4-related systemic autoimmune disease, with review of relevant literatures.</p><sec><title>CASE REPORT</title><p>A 61-year-old male, who had a past medical history of diabetes, coronary artery bypass surgery and idiopathic pulmonary disease, was admitted for the control of his blood sugar level. He complained of general weakness, easy fatigability, and weight loss of 3 kg for 10 days. Laboratory test results were within normal range except for elevated aspartate aminotransferase (100 U/L), alanine transaminase (114 U/L), and alkaline phosphatase (397 U/L). Although serum tumor markers were within normal limits (&#x003b1;-fetoprotein, 2 ng/mL; carcinoembryonic antigen, 1.56 ng/mL; carbohydrate antigen 19-9, 13.71 U/mL), additional tests for malignancy was conducted due to his weight loss. The magnetic resonance cholangiopancreatography disclosed a mass lesion at hilar bile duct. Magnetic resonance imaging (MRI) revealed a 2.1-cm-sized relatively well-demarcated mass at bifurcation of the left hepatic duct. The mass showed high signal intensity in diffusion restriction image and low intensity in apparent diffusion coefficient (ADC) map image, suggestive of type IV hilar cholangiocarcinoma with periductal invasion into underlying hepatic parenchyma (<xref rid="f1-jptm-2015-12-01" ref-type="fig">Fig. 1A</xref>, <xref rid="f1-jptm-2015-12-01" ref-type="fig">B</xref>). Since the patient had type 3 variation of intrahepatic bile duct-prior branching of right posterior Glisson pedicle which made the mass to be located apart from the right posterior duct, the lesion was considered to be resectable. Preoperative evaluation of positron emission tomography (PET) showed multiple enlarged lymph nodes in left axillary, common hepatic, portocaval, and aortocaval areas. Ultrasonography-guided biopsy of the axillary lymph node was performed; however, malignant cell was not identified, suggesting a reactive change rather than metastasis. Clinicians decided to perform surgery with an impression of hilar cholangiocarcinoma. A firm mass was detected at upper hilar level during the operation. Invasion to the left portal vein was suspected and the mass was also close to the right portal vein. Left trisectionectomy was performed for curative resection.</p><p>The resected specimen revealed a white firm mass-like lesion, measuring 2.5 &#x000d7; 2.0 &#x000d7; 1.3 cm, at bifurcation of the left intrahepatic bile duct (<xref rid="f1-jptm-2015-12-01" ref-type="fig">Fig. 1C</xref>). Histologic examination showed an extensive infiltration of lymphocytes and plasma cells (<xref rid="f2-jptm-2015-12-01" ref-type="fig">Fig. 2A</xref>). Storiform fibrosis was noted with a few foci of obliterative phlebitis (<xref rid="f2-jptm-2015-12-01" ref-type="fig">Fig. 2B</xref>). Immunohistochemical staining for IgG and IgG4 showed numerous IgG- and IgG4-immunoreactive plasma cells (<xref rid="f2-jptm-2015-12-01" ref-type="fig">Fig. 2C</xref>, <xref rid="f2-jptm-2015-12-01" ref-type="fig">D</xref>). The IgG4+ plasma cells were identified up to 53 cells per high-power field. IgG4+/IgG plasma cell ratio was 0.42. According to the consensus statement on the pathology of IgG4-RD, the lesion was diagnosed as &#x0201c;histologically highly suggestive of IgG4-RD [<xref rid="b2-jptm-2015-12-01" ref-type="bibr">2</xref>].&#x0201d;</p><p>Following the pathologic diagnosis of IgG4-RD, laboratory tests for serum IgG level was performed and it was within upper normal range in postoperative day 12 (1,522 mg/dL; reference range, 700 to 1,600 mg/dL). All subclasses of IgG were elevated: IgG1, 1,070 mg/dL (reference range, 341 to 894 mg/dL); IgG2, 694 mg/dL (reference range, 171 to 632 mg/dL); IgG3, 134 mg/dL (reference range, 11.5 to 105.3 mg/dL); and IgG4, 257 mg/dL (reference range, 2.4 to 121.0 mg/dL). Thorough investigation for involvement of other organs by IgG4-RD was done, but it failed to identify any additional abnormality. The patient did not receive corticosteroid treatment because no residual lesion was left after the resection and also because he was diabetic.</p><p>After a year, follow-up PET scan revealed an increased fluorodeoxyglucose (FDG) uptake in the biliary trees of right liver, pancreas, and perisplenic soft tissue as well as hypermetabolic lymphadenopathy involving supraclavicular, mediastinal, pulmonary hilar, subcarinal and left abdominal paraaortic lymph nodes, suggestive of progression to extrabiliary multi-organ IgG4-related autoimmune disease (<xref rid="f3-jptm-2015-12-01" ref-type="fig">Fig. 3A</xref>). Serum IgG level had also increased to 3,677 mg/dL, more than twice as high as the initial value. Fluorescent antinuclear antibody test showed 4+ result. The patient started to take prednisone once a day. However, computed tomography (CT) images after prednisone treatment for 6 months revealed subpleural consolidations and enlargement of mediastinal lymph nodes. As prednisone treatment was continued, the extent of subpleural consolidations diminished on the follow-up CT images. A year persistent treatment markedly decreased FDG uptake in bilateral supraclavicular, left axilla, mediastinal, subcarinal, pulmonary hilar, and retroperitoneal left paraaortic lymph nodes on PET scan, reflecting the patient&#x02019;s multi-organ IgG4-RD response to the steroid (<xref rid="f3-jptm-2015-12-01" ref-type="fig">Fig. 3B</xref>).</p><p>This study was approved by the Institutional Review Board of the Samsung Medical Center (IRB No. 2015-10-203).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>IgG4-RD was originally recognized in pancreas as autoimmune pancreatitis [<xref rid="b11-jptm-2015-12-01" ref-type="bibr">11</xref>]. Concomitant extrapancreatic manifestation is not uncommon in bile duct, lymph node, salivary glands, gastric mucosa, and kidney [<xref rid="b1-jptm-2015-12-01" ref-type="bibr">1</xref>,<xref rid="b3-jptm-2015-12-01" ref-type="bibr">3</xref>,<xref rid="b12-jptm-2015-12-01" ref-type="bibr">12</xref>]. Solitary organ involvement without pancreatitis has also been reported [<xref rid="b1-jptm-2015-12-01" ref-type="bibr">1</xref>,<xref rid="b3-jptm-2015-12-01" ref-type="bibr">3</xref>,<xref rid="b4-jptm-2015-12-01" ref-type="bibr">4</xref>]. IgG4-RD tends to present as diffuse lesion in the involved organs, especially in pancreas and biliary tract [<xref rid="b13-jptm-2015-12-01" ref-type="bibr">13</xref>]. Localized mass-forming autoimmune pancreatitis had frequently been misdiagnosed as malignancy and had resulted in unnecessary surgical resections [<xref rid="b6-jptm-2015-12-01" ref-type="bibr">6</xref>,<xref rid="b7-jptm-2015-12-01" ref-type="bibr">7</xref>]. In contrast, mass-forming IgG4-related cholangitis is far less common and most reported cases were identified as long segment smooth narrowing of the bile ducts [<xref rid="b14-jptm-2015-12-01" ref-type="bibr">14</xref>]. <xref rid="t1-jptm-2015-12-01" ref-type="table">Table 1</xref> summarizes clinical, radiological and pathologic characteristics of localized mass-forming IgG4-related cholangitis cases that have been reported to date. Besides our case, all except one presented as hilar or intrahepatic mass accompanied by biliary stricture [<xref rid="b8-jptm-2015-12-01" ref-type="bibr">8</xref>-<xref rid="b10-jptm-2015-12-01" ref-type="bibr">10</xref>]. Since these lesions had often been misdiagnosed as cholangiocarcinoma, many patients had undergone unnecessary resection of liver. IgG4-RD could be diagnosed only after histopathologic examination of the resected specimen, which showed numerous IgG4+ plasma cell infiltrates [<xref rid="b9-jptm-2015-12-01" ref-type="bibr">9</xref>,<xref rid="b15-jptm-2015-12-01" ref-type="bibr">15</xref>,<xref rid="b16-jptm-2015-12-01" ref-type="bibr">16</xref>].</p><p>The case presented here clearly showed a mass lesion in both imaging studies and resected specimen without accompanying biliary stricture. Radiologists also had no doubt that the lesion was malignancy since it was not only a well-defined isolated mass but also it had characteristic features of malignant lesion in many imaging modalities; arterial phase of CT revealed enhancement and the lesion showed high signal intensity on diffusion restriction phase and low intensity on ADC map phase of MRI. Furthermore, the patient lost 3 kg of his weight for 10 days, a suspicious sign of malignancy. Multiple enlarged lymph nodes in our case were also regarded as metastasis from cholangiocarcinoma until the aspiration biopsy proved otherwise. Despite the negative result of aspiration biopsy of the lymph node, hilar cholangiocarcinoma was still suspected, considering the result as false-negative. However, a possibility of nodal manifestation of IgG4-RD should have been considered in this case because systemic nodal metastasis is an unusual finding for cholangiocarcinoma [<xref rid="b17-jptm-2015-12-01" ref-type="bibr">17</xref>].</p><p>Clinical diagnostic criteria to aid detection of IgG4-related sclerosing cholangitis were suggested by a Japanese group [<xref rid="b18-jptm-2015-12-01" ref-type="bibr">18</xref>]. The criteria included four items: (1) characteristic biliary imaging findings, (2) elevation of serum IgG4, (3) coexistence of other IgG4-related disease, and (4) histopathological features. To make definite diagnosis, thorough investigation of clinical, radiologic, laboratory and histopathologic examination is essential; however, all of these examinations are not always performed. Although there are some radiologic characteristics which help distinguish IgG4-related cholangitis from primary sclerosing cholangitis, it is still difficult to exclude hilar cholangiocarcinoma by image alone. Likewise, serum IgG4 level alone is not helpful since its sensitivity and specificity are not high [<xref rid="b19-jptm-2015-12-01" ref-type="bibr">19</xref>]. Some of IgG4-related cholangitis cases showed only minimally elevated serum IgG4 level [<xref rid="b10-jptm-2015-12-01" ref-type="bibr">10</xref>]. Histologic confirmation is necessary for definite diagnosis in this regard. Biopsy seems to be superior to brush cytology because some cases revealed false-positive atypical cells in brush cytology but resection specimen consisted of IgG4+ plasma cells and fibrosis only [<xref rid="b20-jptm-2015-12-01" ref-type="bibr">20</xref>]. Both quantity and quality of the biopsy are crucial for representing the entire lesion and immunohistochemical staining for IgG and IgG4 is required for an ac-curate diagnosis.</p><p>In summary, we report an unusual case of localized mass-forming IgG4-related cholangitis that mimicked hilar cholangiocarcinoma in the initial diagnostic approach. Since isolated mass-forming IgG4-RD without biliary stricture is extremely rare, exclusion of malignancy can be difficult without histopathologic confirmation. Also, the IgG4-related cholangitis in this patient later progressed to the most extensive form of systemic disease reported to date. Although IgG4-related cholangitis is rare, it should be considered in differential diagnosis of a solitary mass in the biliary tree that mimics cholangiocarcinoma, especially when it is accompanied by any evidence of systemic manifestation, including multiple lymphadenopathy and suspicious extrapancreatic organ involvement.</p></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>Conflicts of Interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-jptm-2015-12-01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zen</surname><given-names>Y</given-names></name><name><surname>Nakanuma</surname><given-names>Y</given-names></name></person-group><article-title>IgG4-related disease: a cross-sectional study of 114 cases</article-title><source>Am J Surg Pathol</source><year>2010</year><volume>34</volume><fpage>1812</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21107087</pub-id></element-citation></ref><ref id="b2-jptm-2015-12-01"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Zen</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Consensus statement on the pathology of IgG4-related disease</article-title><source>Mod Pathol</source><year>2012</year><volume>25</volume><fpage>1181</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">22596100</pub-id></element-citation></ref><ref id="b3-jptm-2015-12-01"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>JH</given-names></name><name><surname>Zen</surname><given-names>Y</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name></person-group><article-title>IgG4-related disease</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><fpage>539</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">22316447</pub-id></element-citation></ref><ref id="b4-jptm-2015-12-01"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>VS</given-names></name><name><surname>Mattoo</surname><given-names>H</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Pillai</surname><given-names>SS</given-names></name><name><surname>Stone</surname><given-names>JH</given-names></name></person-group><article-title>IgG4-related disease</article-title><source>Annu Rev Pathol</source><year>2014</year><volume>9</volume><fpage>315</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">24111912</pub-id></element-citation></ref><ref id="b5-jptm-2015-12-01"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>WI</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Lee</surname><given-names>JK</given-names></name><etal/></person-group><article-title>The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis: comparison with chronic pancreatitis and pancreatic cancer</article-title><source>Pancreas</source><year>2009</year><volume>38</volume><fpage>401</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18981953</pub-id></element-citation></ref><ref id="b6-jptm-2015-12-01"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>I</given-names></name><name><surname>Shinzeki</surname><given-names>M</given-names></name><name><surname>Toyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct</article-title><source>J Gastrointest Surg</source><year>2011</year><volume>15</volume><fpage>2296</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21584824</pub-id></element-citation></ref><ref id="b7-jptm-2015-12-01"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naitoh</surname><given-names>I</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer</article-title><source>Scand J Gastroenterol</source><year>2012</year><volume>47</volume><fpage>607</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">22416894</pub-id></element-citation></ref><ref id="b8-jptm-2015-12-01"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Sainani</surname><given-names>NI</given-names></name><name><surname>Chung</surname><given-names>RT</given-names></name><etal/></person-group><article-title>IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material</article-title><source>Mod Pathol</source><year>2009</year><volume>22</volume><fpage>1287</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">19633647</pub-id></element-citation></ref><ref id="b9-jptm-2015-12-01"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zen</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?</article-title><source>Am J Surg Pathol</source><year>2004</year><volume>28</volume><fpage>1193</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">15316319</pub-id></element-citation></ref><ref id="b10-jptm-2015-12-01"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamano</surname><given-names>H</given-names></name><name><surname>Kawa</surname><given-names>S</given-names></name><name><surname>Uehara</surname><given-names>T</given-names></name><etal/></person-group><article-title>Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>62</volume><fpage>152</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15990840</pub-id></element-citation></ref><ref id="b11-jptm-2015-12-01"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamano</surname><given-names>H</given-names></name><name><surname>Kawa</surname><given-names>S</given-names></name><name><surname>Horiuchi</surname><given-names>A</given-names></name><etal/></person-group><article-title>High serum IgG4 concentrations in patients with sclerosing pancreatitis</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>732</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11236777</pub-id></element-citation></ref><ref id="b12-jptm-2015-12-01"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>M</given-names></name><name><surname>Saeki</surname><given-names>T</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><etal/></person-group><article-title>Proposal for diagnostic criteria for IgG4-related kidney disease</article-title><source>Clin Exp Nephrol</source><year>2011</year><volume>15</volume><fpage>615</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">21898030</pub-id></element-citation></ref><ref id="b13-jptm-2015-12-01"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotn&#x000fd;</surname><given-names>I</given-names></name><name><surname>D&#x000ed;t&#x0011b;</surname><given-names>P</given-names></name><name><surname>Trna</surname><given-names>J</given-names></name><name><surname>Lata</surname><given-names>J</given-names></name><name><surname>Husov&#x000e1;</surname><given-names>L</given-names></name><name><surname>Geryk</surname><given-names>E</given-names></name></person-group><article-title>Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease</article-title><source>Dig Dis</source><year>2012</year><volume>30</volume><fpage>216</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22722442</pub-id></element-citation></ref><ref id="b14-jptm-2015-12-01"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>V</given-names></name></person-group><article-title>IgG4-related disease of the gastrointestinal tract: a 21st century chameleon</article-title><source>Arch Pathol Lab Med</source><year>2015</year><volume>139</volume><fpage>742</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">26030243</pub-id></element-citation></ref><ref id="b15-jptm-2015-12-01"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>A</given-names></name><name><surname>Sakuma</surname><given-names>Y</given-names></name><name><surname>Ohzawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Immunoglobulin g4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case</article-title><source>Int Surg</source><year>2015</year><volume>100</volume><fpage>480</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">25785331</pub-id></element-citation></ref><ref id="b16-jptm-2015-12-01"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>RP</given-names></name><name><surname>Smyrk</surname><given-names>TC</given-names></name><name><surname>Chari</surname><given-names>ST</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Isolated IgG4-related sclerosing cholangitis: a report of 9 cases</article-title><source>Hum Pathol</source><year>2014</year><volume>45</volume><fpage>1722</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24890945</pub-id></element-citation></ref><ref id="b17-jptm-2015-12-01"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheuk</surname><given-names>W</given-names></name><name><surname>Yuen</surname><given-names>HK</given-names></name><name><surname>Chu</surname><given-names>SY</given-names></name><name><surname>Chiu</surname><given-names>EK</given-names></name><name><surname>Lam</surname><given-names>LK</given-names></name><name><surname>Chan</surname><given-names>JK</given-names></name></person-group><article-title>Lymphadenopathy of IgG4-related sclerosing disease</article-title><source>Am J Surg Pathol</source><year>2008</year><volume>32</volume><fpage>671</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">18344866</pub-id></element-citation></ref><ref id="b18-jptm-2015-12-01"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohara</surname><given-names>H</given-names></name><name><surname>Okazaki</surname><given-names>K</given-names></name><name><surname>Tsubouchi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012</article-title><source>J Hepatobiliary Pancreat Sci</source><year>2012</year><volume>19</volume><fpage>536</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">22717980</pub-id></element-citation></ref><ref id="b19-jptm-2015-12-01"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazaridis</surname><given-names>KN</given-names></name></person-group><article-title>Sclerosing cholangitis epidemiology and etiology</article-title><source>J Gastrointest Surg</source><year>2008</year><volume>12</volume><fpage>417</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17957439</pub-id></element-citation></ref><ref id="b20-jptm-2015-12-01"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>DT</given-names></name><name><surname>Tang</surname><given-names>CN</given-names></name><name><surname>Lai</surname><given-names>EC</given-names></name><name><surname>Yang</surname><given-names>GP</given-names></name><name><surname>Li</surname><given-names>MK</given-names></name></person-group><article-title>Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma</article-title><source>Hong Kong Med J</source><year>2010</year><volume>16</volume><fpage>149</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">20354252</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-jptm-2015-12-01" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Magnetic resonance imaging reveals an enhancing mass lesion which has high signal intensity on diffusion restriction phase (A) and low intensity on apparent diffusion coefficient map phase (B), suspicious for malignancy. (C) The cut section of hilar bile duct shows a relatively well-demarcated mass-forming lesion with a hepatic parenchymal invasion.</p></caption><graphic xlink:href="jptm-2015-12-01f1"/></fig><fig id="f2-jptm-2015-12-01" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Histologic examination reveals dense infiltration of lymphocytes and plasma cells (A) and storiform fibrosis (B). Both IgG-immunopositive (C) and IgG4-immunopositive (D) plasma cells are identified by immunohistochemical staining.</p></caption><graphic xlink:href="jptm-2015-12-01f2"/></fig><fig id="f3-jptm-2015-12-01" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>(A) Fluorodeoxyglucose (FDG) positron emission tomography&#x02013;computed tomography, maximum intensity projection image show hypermetabolic lesions involving bilateral supraclavicular, left axillar, mediastinal, pulmonary hilar and retroperitoneal lymph nodes, right liver biliary tract, pancreas, and perisplenic area. (B) After steroid treatment, markedly decreased FDG uptake is noted although uptakes in some lymph nodes are still seen.</p></caption><graphic xlink:href="jptm-2015-12-01f3"/></fig><table-wrap id="t1-jptm-2015-12-01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Clinicopathological findings of previously reported cases of mass-forming IgG4-related cholangitis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Reference</th><th align="center" valign="middle" rowspan="1" colspan="1">Sex</th><th align="center" valign="middle" rowspan="1" colspan="1">Age (yr)</th><th align="center" valign="middle" rowspan="1" colspan="1">Specimen type</th><th align="center" valign="middle" rowspan="1" colspan="1">Site</th><th align="center" valign="middle" rowspan="1" colspan="1">Symptom</th><th align="center" valign="middle" rowspan="1" colspan="1">Radiologic finding</th><th align="center" valign="middle" rowspan="1" colspan="1">IgG4 count (/HPF)</th><th align="center" valign="middle" rowspan="1" colspan="1">Sequence of biliary manifestation</th><th align="center" valign="middle" rowspan="1" colspan="1">Other manifestations</th><th align="center" valign="middle" rowspan="1" colspan="1">Serum IgG4/IgG</th><th align="center" valign="middle" rowspan="1" colspan="1">Follow-up</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Present case</td><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">Hilum</td><td align="center" valign="top" rowspan="1" colspan="1">Fatigue, weight loss</td><td align="center" valign="top" rowspan="1" colspan="1">Localized mass</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">Pancreas, pleura, LN, perisplenic soft tissue</td><td align="center" valign="top" rowspan="1" colspan="1">257/1,522</td><td align="center" valign="top" rowspan="1" colspan="1">Response on steroids</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">Deshpande et al. [<xref rid="b8-jptm-2015-12-01" ref-type="bibr">8</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">68</td><td align="center" valign="top" rowspan="1" colspan="1">Biopsy</td><td align="center" valign="top" rowspan="1" colspan="1">Liver and IBD</td><td align="center" valign="top" rowspan="1" colspan="1">Jaundice</td><td align="center" valign="top" rowspan="1" colspan="1">Vague mass with alternate narrowing and dilatation of IBD</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">Salivary gland, retroperitoneum</td><td align="center" valign="top" rowspan="1" colspan="1">4,160/3,580</td><td align="center" valign="top" rowspan="1" colspan="1">Response on steroids</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">F</td><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">Hilum</td><td align="center" valign="top" rowspan="1" colspan="1">Hepatic hilar mass</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">140</td><td align="center" valign="top" rowspan="1" colspan="1">Secondary</td><td align="center" valign="top" rowspan="1" colspan="1">Pancreas</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">No steroid use</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hamano et al. [<xref rid="b10-jptm-2015-12-01" ref-type="bibr">10</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">F</td><td align="center" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">Biopsy</td><td align="center" valign="top" rowspan="1" colspan="1">CBD</td><td align="center" valign="top" rowspan="1" colspan="1">Abdominal pain, jaundice</td><td align="center" valign="top" rowspan="1" colspan="1">Mass with long CBD narrowing</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">122/1,711</td><td align="center" valign="top" rowspan="1" colspan="1">Response on steroids</td></tr><tr><td align="left" valign="top" rowspan="5" colspan="1">Zen et al. [<xref rid="b9-jptm-2015-12-01" ref-type="bibr">9</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">IBD</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">Mass with irregular stricture</td><td align="center" valign="top" rowspan="1" colspan="1">+++<sup><xref rid="tfn1-jptm-2015-12-01" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">79</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">IBD</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">Mass with irregular stricture</td><td align="center" valign="top" rowspan="1" colspan="1">+++<sup><xref rid="tfn1-jptm-2015-12-01" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">56</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">IBD</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">Mass with irregular stricture</td><td align="center" valign="top" rowspan="1" colspan="1">+++<sup><xref rid="tfn1-jptm-2015-12-01" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">LN</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">64</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">IBD</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">Mass with irregular stricture</td><td align="center" valign="top" rowspan="1" colspan="1">+++<sup><xref rid="tfn1-jptm-2015-12-01" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">LN</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">67</td><td align="center" valign="top" rowspan="1" colspan="1">Resection</td><td align="center" valign="top" rowspan="1" colspan="1">Left HD</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">Mass with irregular stricture</td><td align="center" valign="top" rowspan="1" colspan="1">+++<sup><xref rid="tfn1-jptm-2015-12-01" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Initial</td><td align="center" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn><p>HPF, high power field; M, male; LN, lymph node; IBD, intrahepatic bile duct; F, female; NA, not available; CBD, common bile duct; HD, hepatic duct.</p></fn><fn id="tfn1-jptm-2015-12-01"><label>a</label><p>The number of IgG4-immunopositive plasma cells is not counted; semiquantitative score is used instead.</p></fn></table-wrap-foot></table-wrap></floats-group></article>